Behavioral Program for Weight Loss After Stopping GLP-1 Medications
Part of Hormones & metabolism clinical trials.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You lost 15% or more of your body weight using anti-obesity medication (like GLP-1 drugs)
- You stopped your weight-loss medication within the last 4 weeks or plan to stop before the study starts
- You have gained back 3 kg (about 6–7 pounds) or less in the past 3 months
- You can attend in-person visits at baseline, 3 months, and 6 months, plus join virtual sessions over 6 months
- You have internet access and speak English well enough to complete study activities
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an extended care program designed to help people keep weight off after losing it. You would join with a buddy (friend or family member) and attend online sessions via Zoom, along with a few in-person check-ins at the university.
This study looks at how GLP-1 medications (like Ozempic or Wegovy) combined with behavioral coaching through Noom affect weight loss and metabolic health over 12 months. You may qualify if you're interested in weight loss and willing to commit to a program for a year.
This study tests if two different diet programs can help people maintain weight loss for 12 months after stopping a GLP-1 medication (like Ozempic or Wegovy).
This study tests a digital program to help adults lose weight using behavioral strategies. You will use your phone, a scale, and email to track progress and get support.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
Hear when a new Weight Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.